Novel Molecular Diagnostic Tests
The CertNDx™ Bladder Cancer Assays are a suite of molecular diagnostic tests to help improve the detection, diagnosis and management of bladder cancer.
Non-Invasive Urine Tests
The CertNDx urine tests are designed to stratify the population based on the likelihood of disease. CertNDx testing can be used for Hematuria Assessment to rule out bladder cancer with high confidence and determine the likelihood of disease. It can also be used for Recurrence Monitoring to determine the likelihood of disease recurrence in patients previously diagnosed with bladder cancer.
Our tests when used in conjuction with cytology and other standard tools provide a quantitative test across all stages of bladder cancer.
We also offer a tissue-based Molecular Grading test to determine a molecular grade and the risk of progression of bladder cancer.